US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
Sunniva Inc (SNN) 銘柄情報

Sunniva Inc (SNN)

0.155

0.00

(0.00%)

終了 6月12日 5:00AM

Sunniva Inc (SNN) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.155

( - )

買値

0.05

売値

0.145

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.155

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 7,712

発行済株式数

795,750,102

配当利回り

PER

-0

1 株当たり利益 (EPS)

-1.31

歳入

35.04M

純利益

-49.98M

Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its pro... Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.sunniva.com

本社

Vancouver, Canada

設立

2026

Sunniva Inc is listed in the sector of the Canadian Securities Exchange with ticker SNN. The last closing price for Sunniva was $0.16. Over the last year, Sunniva shares have traded in a share price range of $ 0.00 to $ 0.00.

Sunniva currently has 795,750,102 shares in issue. The market capitalisation of Sunniva is $123.34 million. Sunniva has a price to earnings ratio (PE ratio) of -0.00.

Smith & Nephew New DYONICS(TM) RF System Enables Surgeons to Quickly and Precisely Remove Soft Tissue Using RF Energy

ANDOVER, Mass., Feb. 24 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN)(LSE:SN) Endoscopy Division today announced the launch of the...

The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in Hamburg

HAMBURG, Feb. 3 /PRNewswire-FirstCall/ -- The International Negative Pressure Wound Therapy (NPWT) Expert Panel will be hosting a global...

Smith & Nephew Endoscopy Awarded Contract From Healthtrust Purchasing Group

ANDOVER, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN); (LSE:SN) Endoscopy Division today announced that the company has...

Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments

MEMPHIS, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Medical device maker Smith & Nephew's (NYSE:SNN)(LSE:SN) Orthopaedics business is making...

Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.

HULL, England and FT. SASKATCHEWAN, Canada, Dec. 22 /PRNewswire-FirstCall/ -- The Advanced Wound Management division of Smith & Nephew plc...

Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries

"Fracture putty" system to improve standard of care for injured soldiers MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/ -- Smith & Nephew (NYSE:...

Smith & Nephew Endoscopy Announces Availability of TRUCLEAR(TM) Hysteroscopic Morcellator at the AAGL Annual Meeting

Innovative System Allows for Efficient Removal of Intrauterine Polyps and Fibroids ANDOVER, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Smith...

Centers for Medicare & Medicaid Services Retain Single NPWT Code

Significant decision will benefit patients, providers ST. PETERSBURG, Fla., Nov. 9 /PRNewswire/ -- The Advanced Wound Management division of...

Smith & Nephew Orthopaedics Donates Inaugural Funds to COTA Grants Program

MEMPHIS, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN)(LSE:SN) Orthopaedics business announced today it has made a...

New Website Launched for Patients With Broken Bones

www.exogen.com - new information resource for people seeking active role in recovery RALEIGH, N.C. and DURHAM, N.C., Sept. 29...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

SNN - Frequently Asked Questions (FAQ)

What is the current Sunniva Inc share price?

The current share price of Sunniva Inc is $ 0.155

How many Sunniva Inc shares are in issue?

Sunniva Inc has 795,750,102 shares in issue

What is the market cap of Sunniva Inc?

The market capitalisation of Sunniva Inc is CAD 123.34M

What is the 1 year trading range for Sunniva Inc share price?

Sunniva Inc has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Sunniva Inc?

The price to earnings ratio of Sunniva Inc is -0

What is the cash to sales ratio of Sunniva Inc?

The cash to sales ratio of Sunniva Inc is 0

What is the registered address of Sunniva Inc?

The registered address for Sunniva Inc is 1200 Waterfront Centre, Vancouver, British Columbia, V6C 3L6

What is the Sunniva Inc website address?

The website address for Sunniva Inc is www.sunniva.com

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 5分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 6分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 8分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 11分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 12分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 13分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 14分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 15分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 16分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 18分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 19分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Lord Andreti

Lord Andreti 20分前

It’s far from going to no bid. Bid is high AF right now and not something you see daily around the OTC market.

Something is brewing and this is for sure going places (bid still gives the biggest tells)…I just don’t think it’s going be that big of a deal, anymore, after this crap.

OMOLIVES

OMOLIVES 20分前

Also, look at the past six Months. They had 7.5 - 1 Billion volume days over the past six Months. Backlog, bottleneck....fucked.

Just give me $1.50

Just give me $1.50 24分前

Does this mean every penny spent on this case was a complete waste of time since we can't launch until the patents are up?

Or in other words, we got absolutely nothing out of it, except losing money on attorney fees?

So Elite failed?

Thanks.

along4zride

along4zride 24分前

BIG IPO TOMORROW. Real company on major exchange. Excitement enthusiasm, whole world watching. Will be setting a benchmark for all going forward. Not some pink sheet (FNMA) wanna be has been in conservatorship with total profit sweep waiting for a hand out . Most can recognize the difference. I am

nowwhat2

nowwhat2 24分前

The 200 = Wow
https://schrts.co/CWanBemw

https://investorshub.advfn.com/uimage/uploads/2026/6/12/pynusbag_june_11_sweet_but_vol.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dwwgnbag_june_11_snip_vol_nuts.jpg

https://i

Oleblue

Oleblue 27分前

Chad Williams, CEO of Honey Badger Silver Inc. | Rule Symposium 2026: Rick Rule interviews

https://youtu.be/zGol2-Jz7p8

Got Germanium and Tungsten?

Daily Chart
https://schrts.co/kbyFeMMu

JimBoStevens

JimBoStevens 30分前

That Weekly W% up and Sto down, while pinching OMFG spells KaBoom to me

Overall Market will be crazy tomorrow perfect timing... well see just dont see a better time then now

Just give me $1.50

Just give me $1.50 30分前

We have INDEED met the requirement of at least 10 likes.

Therefore, AS PROMISED, here are the documents (11 pages):

STIPULATION of Dismissal and Proposed Order Regarding Irrevocable Covenant Not to Come to Market by ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC.

jour_trader

jour_trader 32分前

That’s great insight. Thanks for sharing. At least 14 months away from launch and going into final stages of FDA decision. Wonder where Accord is in the process.

Tami Senior Securitisati...

Telix Pharmaceuticals

iNAV db xtrackers FTSE A...

Manulife Money Market Fu...

Amundi MSCI AC Asia Paci...

Arizona Gold and Silver

Exchange Traded

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。